North America Outpatient Central Fulfillment Market Forecast to 2030 - Regional Analysis - by Product Type and End User

The North America outpatient central fulfillment market was valued at US$ 152.56 million in 2022 and is expected to reach US$ 350.50 million by 2030; it is estimated to record a CAGR of 11.0% from 2022 to 2030.

Automation in Pharmacies Drives North America Outpatient Central Fulfillment Market

Pharmacy automation has become one of the most flourishing segments of the healthcare sector. The automation technology can improve patient care and increase efficiency by automating pharmacy tasks and processes. According to a study by Visionary Insights, automation in pharmacies was predicted to increase by 22% each year through 2021. This rise can be attributed to the growing need for precise and efficient dispensing, and the increasing number of specialty medication dispensing operations.

A study by Oracle Cerner states that the automated dispensing of specialty medications was one of the most performed tasks in pharmacies. The study also states that pharmacy automation can improve accuracy (and reduce errors), speed up the process, and improve patient care. Pharmacists also adopt technologies to automate certain other tasks than dispensing, e.g., inventory management. Automated inventory systems can help pharmacies track and manage their inventory more accurately.

Leading pharmacy automation system vendors continuously focus on developing and introducing their innovations. In February 2021, Omnicell Inc. announced the launch of its Medimat, a next-generation, automated dispensing system for retail pharmacies. It has been built for improved patient safety, efficient time utilization, and financial savings. Similarly, in August 2021, innovative Aspirations (iA), a commercial provider of software-enabled pharmacy fulfillment and automation solutions, launched three solutions integrated with Medimat's NEXiA technology to manage the fulfillment of prescribed medicines centrally.

iA has also introduced SmartPod, a next-generation robot with a modular autofill unit. SmartPod allows pharmacy providers to adjust and scale their centralized fulfillment solutions. Thus, the growing adoption of automation in pharmacies with the introduction of next-generation automated systems fuels the growth of the outpatient central fulfillment market.

North America Outpatient Central Fulfillment Market Overview

The outpatient central fulfillment market in the US is growing mainly with the rising medication errors and surging demand for pharmaceutical products. An increased patient population in the US indicates a large number of patients taking multiple medicines daily. Patients who take multiple medications are at an increased risk of medication errors, which can cause health risks in patients. Therefore, healthcare organizations rely on modern technologies such as automation systems to avoid medication errors.

As a result, the demand for precise robotic equipment and tools to perform tasks faster are expected to be the key factors for market growth. According to Zippia, in 2021 the pharmaceutical industry in the US generated US$ 55 billion, accounting to 48% of the global pharmaceutical market. Thus, the US dominated the pharmaceutical market, exhibiting a growing trend in demand and drug development.

North America Outpatient Central Fulfillment Market Segmentation

The North America outpatient central fulfillment market is segmented based on product type, end user, and country. Based on product type, the North America outpatient central fulfillment market is segmented into automated medication dispensing systems, automated packaging and labelling systems, automated tabletop counters, automated storage and retrieval systems, and others. The automated medication dispensing systems segment held the largest market share in 2022.

• In terms of end user, the North America outpatient central fulfillment market is categorized into hospital pharmacies, retail pharmacies, and mail-order pharmacies. The hospital pharmacies segment held the largest market share in 2022.
• Based on country, the North America outpatient central fulfillment market is segmented into the US, Canada, and Mexico. The US dominated the North America outpatient central fulfillment market share in 2022.

Tension Envelope Corp, ScriptPro LLC, Cardinal Health Inc, Omnicell Inc, Becton Dickinson and Co, RxSafe LLC, Custom Health Inc, Capsa Solutions LLC, Surescripts LLC, and McKesson Corp are some of the leading players operating in the North America outpatient central fulfillment market.